Tamoxifen citrate: A glimmer of hope for silicosis

Journal of Surgical Research

Volumn 193, Issue 1, 2015, Pages 429-434

  Yoldas, Omer ^a   Karaca, Turgut ^b   Bilgin, Bulent Caglar ^c   Yilmaz, Omer Hinc ^d   Simsek, Gulcin Guler ^e   Alici, Ibrahim Onur ^d   Uzdogan, Andaç ^f   Karaca, Nihal ^g   Akin, Tezcan ^h   Yoldas, Suna ⁱ   Akbiyik, Filiz ^f  

^a IZMIR UNIVERSITY   (Turkey)

^b Iskenderun State Hospital   (Turkey)

^c KAFKAS UNIVERSITY   (Turkey)

^d ANKARA OCCUPATIONAL DISEASES HOSPITAL   (Turkey)

^e Keçiören Education and Research Hospital ^*  (Turkey)

^f HACETTEPE UNIVERSITY   (Turkey)

^g ANKARA UNIVERSITY   (Turkey)

^h ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

ⁱ Departments of Pediatric Infectious Diseases   (Turkey)

Author keywords

Fibrosis; Silicosis; Tamoxifen; TGF ; Treatment

Indexed keywords

HEMATOXYLIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN CITRATE; TRANSFORMING GROWTH FACTOR BETA; NANOPARTICLE; SILICON DIOXIDE; TAMOXIFEN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; IMMUNOHISTOCHEMISTRY; LUNG FIBROSIS; LUNG INJURY; NONHUMAN; OLIGOSPERMIA; PNEUMONIA; PRIORITY JOURNAL; RAT; SILICOSIS; TISSUE ADHESION; ANIMAL; DISEASE MODEL; METABOLISM; PATHOLOGY; PULMONARY FIBROSIS; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; NANOPARTICLES; PULMONARY FIBROSIS; RATS, WISTAR; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SILICON DIOXIDE; SILICOSIS; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 84925031209     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.08.013     Document Type: Article

References (21)

1. Lin W, Huang YW, Zhou XD, Ma Y. In vitro toxicity of silica nanoparticles in human lung cancers. Toxicol Appl Pharmacol 2006;217:252.
2. Sun Y, Yang F, Yan J, et al. New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxideinduced silicosis. Life Sci 2010;87:232.
3. Ho GH, Ji CY, Phang BH, Lee KO, Soo KC, Ng EH. Tamoxifen alters levels of serum insulin-like growth factors and binding proteins in postmenapausal breast cancer patients: a prospective paired cohort study. Ann Surg Onco 1998;5:361.
4. Wahl SM, Hunt DA, Wong HL, et al. Transforming growth factor-b is a potent immune supressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol 1988;140: 3026.
5. Karaca T, Yoldas O, Bilgin BC, Ozer S, Yoldas S, Karaca NG. Comparison of short-term results of modified Karydakis flap and modified Limberg flap for pilonidal sinus surgery. Int J Surg 2013;11:68.
6. Ryu SH, Chung YH, Lee JK, et al. Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis. Liver Int 2009;29:308.
7. Mikulec AA, Hanasono MM, Lum J, Kadleck JM, Kita M, Koch RJ. Effect of tamoxifen on transforming growth factor beta1 production by keloid and fetal fibroblasts. Arch Facial Plast Surg 2001;3:111.
8. Ulvestad B, Bakke B, Melbostad E, Fuglerud P, Kongerud J, Lund MB. Increased risk of obstructive pulmonary disease in tunnel workers. Thorax 2000;55:277.
9. Reis M. Silicosis: dangerous from many angles. Stone World 2006;23:16.
10. Nash JL. Why are so many exposed. Occup Hazards 2004;66: 30.
11. Karadag Ö.K, Akkurt I, Önal B, et al. Tas ocaklar? iscilerinde silikozis ve solunumsal bulgular. Tü berkü loz ve Toraks Dergisi 2001;49:73.
12. Castranova V, Porter D, Millecchia L, Ma JY, Hubbs AF, Teass A. Effect of inhaled crystalline silica in a rat model: time course of pulmonary reactions. Mol Cell Biochem 2002; 234-235:177.
13. Olbruch H, Seemayer NH, Wilhelm M. Supernatants from quartz dust treated human macrophages stimulate cell proliferation of different human lung cells as well as collagen synthesis of human diploid lung fibroblasts in vitro. Toxicoljang Mk, Lett 1998;96:85.
14. Barbarin V, Arras M, Huax F. Characterization of the effect of interleukin 10 on silica induced lung fibrosis in mice. Am J Respir Crit Care Med 2004;31:78.
15. Jagirdar J, Begin R, Dufresne A, Goswami S, Lee TC, Rom WN. Transforming growth factor-beta (TGF-beta) in silicosis. Am J Respir Crit Care Med 1996 Oct;154(4 Pt 1):1076.
16. Zhang X, Liang JH, Liang SK, et al. Combination of compound Xuanju capsule and tamoxifen citrate for idiopathic oligozoospermia. Zhonghua Nan Ke Xue 2012;18:661.
17. Payne WG, Ko F, Anspaugh S, Wheeler CK, Wright TE, Robson MC. Down-regulating causes of fibrosis with tamoxifen: a possible cellular/molecular approach to treat rhinophyma. Ann Plast Surg 2006;56:301.
18. Few J, Thompson NW, Angelos P, Simeone D, Giordano T, Reeve T. Riedel's thyroiditis: treatment with tamoxifen. Surgery 1996;120:993.
19. Kuhn MA, Wang X, Payne WG, Ko F, Robson MC. Tamoxifen decreases fibroblast function and downregulates TGF (beta2) in dupuytren's affected palmar fascia. J Surg Res 2002;103: 146.
20. Nilsson UW, Jönsson JA, Dabrosin C. Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cellsea post-translational regulation involving matrix metalloproteinase activity. Exp Cell Res 2009;315:1.
21. Kim D, Lee AS, Jung YJ, et al. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor a-mediated transforming growth factor-b1/Smad signaling pathway. Nephrol Dial Transpl; 2014. pii: gfu240.